Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls

Clinical trial NCT04508309 · COMPLETED

Trial details

NCT number: NCT04508309
Sponsor: PATH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2021-03-15
Primary completion: 2023-12-14
Enrollment: 1025

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.